Czechia· CZ-0055500
HALSET
A cetylpyridinium product containing cetylpyridinium chloride monohydrate, registered in Czechia by Gebro Pharma GmbH, Fieberbrunn. The same ATC class is registered in 4 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Cetylpyridinium is registered in 4 of 19 countries.
Countries holding a registration under ATC R02AA06 (cetylpyridinium), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 3 of them publish a price we can compare per daily dose
Cetylpyridinium · ATC R02AA06
4 / 19 countries
- Canada
- Czechiaprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- CETYLPYRIDINIUM CHLORIDE MONOHYDRATE
- Manufacturer
- Gebro Pharma GmbH, Fieberbrunn
- Country
- Czechia (CZ)
- ATC code
- R02AA06
- ATC class
- Cetylpyridinium
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for cetylpyridinium.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cetylpyridinium · interactions on record
1 record
- 1 moderate
Most severe, free to view
- Hyaluronic acidM09AX01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cetylpyridinium in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAHLO PRO Healthy GumsGervest USA Inc
- CanadaANTISEPTIC ORAL RINSESAGE PRODUCTS LLC
- United KingdomAnbesol liquidAlliance Pharmaceuticals Ltd
- FranceNOVOPTINE 0,1 mg/0,4 ml, collyre en récipient unidoseSIFI (ITALIE)
- NorwayPyriseptKaro Pharma AS
- PolandHalsetBiofarm Sp. z o.o.
- GermanyAnginettenDivapharma Gmbh
- Japanセチルピリジニウム塩化物水和物岩城製薬
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Halset
- Germany · Anginetten, Halstabletten - Akute Hals- Und Rachenhilfe Zur Anwendung Bei Erwachsenen Und Kindern Ab 3 Jahren
- France · Sedacollyre
- United Kingdom (Northern Ireland) · Antiseptic, First Aid Antiseptic
- Italy · Cetilsan, Cetilsan Senza Zucchero
- Malta · Cetilsan Sugar Free
- Norway · Pyrisept
- Poland · Halset, Septolete Junior
- Slovenia · Neoseptolete Z Okusom Divje Češnje, Neoseptolete Z Okusom Limone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/707656a5-f3e5-49ca-95a3-b700f40625cb GET /v1/drugs/707656a5-f3e5-49ca-95a3-b700f40625cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "PAS",
"source": "sukl",
"strength": "1,5MG",
"pack_size": "24",
"substance": "CETYLPYRIDINIUM CHLORIDE MONOHYDRATE",
"cz_kod_sukl": "0055500",
"product_type": "CH",
"substance_codes": "12418",
"registration_state": "R",
"registration_number": "69/205/98-C"
}See everything about cetylpyridinium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.